Yet again, leaders within the federal government have announced continued efforts to root out bad actors who are using the healthcare system for their own personal gain. A recent announcement by the Department of Justice’s (DOJ) National Fraud Enforcement Division highlights this focus, directing prosecutors to double down on investigations of healthcare fraud schemes throughout the country.
What has changed?
The Justice Department’s updated memo represents a significant shift in how federal prosecutors will pursue healthcare fraud cases. This policy framework emphasizes individual accountability and demands greater transparency from healthcare organizations under investigation. The memo makes clear that corporate cooperation alone will not shield companies from prosecution; instead, prosecutors will evaluate the quality and timeliness of that cooperation.
Healthcare executives should recognize that this directive fundamentally alters the enforcement landscape. Corporate settlements that leave individual wrongdoers unscathed will not satisfy the government. Instead, federal authorities commit to identifying and prosecuting the people responsible for fraudulent schemes.
What are the most important provisions healthcare providers should know about?
The updated enforcement guidelines contain several elements that directly impact healthcare providers and organizations. Three of the more important include:
- The DOJ will consider the speed of self-disclosure and the thoroughness of internal investigations when evaluating cooperation
- Repeat offenders and recidivist companies will face enhanced scrutiny and harsher penalties
- The DOJ encourages protection of those who disclose information related to fraud, even those who participated in the criminal conduct
Healthcare providers and organizations are wise to take the announcement seriously. Review internal audit processes and take proactive steps to align compliance programs with these new expectations and mitigate the risk of allegations of healthcare fraud.
The message from the Justice Department is clear: healthcare fraud will be met with serious consequences, and organizations that fail to police themselves will face the full force of federal prosecution. By understanding these new guidelines and adapting compliance programs accordingly, healthcare leaders can protect their institutions from these enhanced efforts.
Attorney John Rivas is responsible for this communication.